Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
Titel:
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
Auteur:
Heller, Simon Buse, John Fisher, Miles Garg, Satish Marre, Michel Merker, Ludwig Renard, Eric Russell-Jones, David Philotheou, Areti Francisco, Ann Marie Ocampo Pei, Huiling Bode, Bruce